Testing effectiveness (Phase 2)Study completedNCT00003304
What this trial is testing
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 29